Accel Diagnostics (United States)
About
Accel Diagnostics is medical diagnostic company developing proprietary point-of-care diagnostic assay for the diagnosis, monitoring and management of a wide variety of medical conditions. We are dedicated to making a difference in the quality of life of millions of patients through technology and innovation. AccelDx’s technology enables patients and healthcare providers to perform lab-quality medical diagnostic tests anytime and anywhere. The Company's patented platform technology transforms the patient blood testing paradigm, from lab-centered to near-patient. The technology bringing significant advantages in terms of simplicity, time to result, care delivery, and cost over current standard lab-based diagnostics. During COVID-19 pademic Accel Diagnostics began to operate the ADX Diagnostic Lab to provide high quality COVID testing in Houston, TX.
Founders
- Alberto Gandini
Investors
News
- List of Diagnostics Companies in Texas - BiopharmIQ · 2025-06-23T00:00:00.000Z
- Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance · 2025-03-21T17:52:00.000Z
- AST Revolution, LLC Launches Following Acquisition of Accelerate Diagnostics Assets · 2025-09-16T00:00:00.000Z
- Accelerate Diagnostics: 97-Day Credit Bid Sale Case · 2026-03-06T06:43:07.000Z
- Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System | Nasdaq · 2024-09-30T00:00:00.000Z
- Accelerate Diagnostics gets FDA nod for Accelerate Arc system and BC kit · 2024-10-01T07:18:09.000Z
Browse similar startups
Related startups
- Alliance Family Medicine — Flower Mound, TX
- American Garage Inc — Coppell, TX
- Ann Shippy, MD, P.A. — Austin, TX
- Bairitone Health — Houston, TX
- Beneloyal Health — Houston, TX
- Blossend — Austin, TX
- AccelerOnc Studio — Tampa, FL
- Access Heart — Weston, WI
- Acclaim Health Analytics, LLC — Benton, KY
- AccuMix Pharmacy — Elmhurst, IL
- AccurKardia — New York, NY
- Acie® Inc. — Bedford, MA
Profile updated Jul 29, 2026. Sources: acceldx.com


